Ashley Rhodes
Adolescent Medicine · Monteagle, TNNPI 1962852103
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $530 and has fallen 93.9% since, to $32 in 2024.
Across 61 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$222
- Baxter Healthcare$100
- AbbVie$94
- AstraZeneca$79
- Esperion Therapeutics, Inc.$77
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$75
- plus $443 from 18 others
What the payments were for
- Food & beverage$1,089100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,089 in reported general payments places this provider in the 70th percentile of 34 adolescent medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $42,371 |
| OzempicSemaglutide | 25 | $38,142 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $25,351 |
| JardianceEmpagliflozin | 21 | $20,267 |
| FarxigaDapagliflozin Propanediol | 25 | $17,831 |
| XareltoRivaroxaban | 16 | $13,631 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 47 | $1,679 |
| Atorvastatin Calcium | 178 | $1,367 |
| Levothyroxine Sodium | 131 | $1,045 |
| Gabapentin | 71 | $906 |
| Losartan Potassium | 120 | $901 |
| Omeprazole | 50 | $723 |
| Lisinopril | 99 | $600 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $565 |
| Metoprolol Succinate | 68 | $455 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $222 | $38,14225 claims |
| GSKTrelegy Ellipta | $19 | $25,35120 claims |
| Boehringer IngelheimJardiance | $53 | $20,26721 claims |
| AstraZenecaFarxiga | $79 | $17,83125 claims |
| Johnson & JohnsonXarelto | $13 | $13,63116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 34 adolescent medicine providers in Tennessee.
Other adolescent medicine in Monteagle
- Martha BowdenMemphis$50K
- Ara HanissianCollierville$26K
- Alston WarrGermantown$7K
- Mary RomanoNashville$5K
- Lea LundHendersonville$3K
- Landon CombsGray$2K
- Stephen CombsGray$2K
- Catherine SipeSmyrna$2K
- Lloyd FranklinCookeville$1K
- John HeiseChattanooga$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.